VeraBIND Tau test, a novel plasma assay for active tau pathology, identifies individuals with positive tau‐PET signal, regardless of amyloid status

Abstract

Background: Plasma assays targeting tau phospho‐epitopes (e.g., pTau217) are frequently observed in the context of isolated amyloid‐β pathology (A+). Developing plasma assays associated with tau aggregation (T+) is an unmet challenge.